Abstract
Background Previously, a study using a sample of the Adolescent Brain Cognitive Development (ABCD)® study from the earlier 1.0 release found differences in several resting state functional MRI (rsfMRI) brain connectivity measures associated with children reporting anhedonia. Here, we aim to reproduce, replicate, and extend the previous findings using data from the later ABCD study 4.0 release, which includes a significantly larger sample.
Methods To reproduce and replicate the previous authors’ findings, we analyzed data from the ABCD 1.0 release (n = 2437), in an independent subsample from the newer ABCD 4.0 release (n = 6456), and in the full ABCD 4.0 release sample (n = 8866). Additionally, we assessed whether using a multiple linear regression approach could improve replicability by controlling for the effects of comorbid psychiatric conditions and socio-demographic covariates.
Results We could only replicate the significant association between anhedonia and the Within Cingulo-Opercular network connectivity measure in an independent subsample of the ABCD 4.0 data release. When using the larger full ABCD 4.0 sample, six out of the eleven previously reported associations remained significant. Accounting for socio-demographic covariates and comorbid conditions using multiple linear regression did not improve replicability but allowed for the identification of specific and independent effects of anhedonia on 16 rsfMRI connectivity measures in the full ABCD 4.0 release sample.
Conclusion Replication of previous findings were limited. A multiple linear regression approach helped resolve the specificity of rsfMRI connectivity associations with anhedonia.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We are performing secondary data analysis using de-identified data. No IRB/oversight body approval was required.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data files are available from the ABCD Study Data Repository from the NIMH Data Archive (https://nda.nih.gov/abcd). The DOI for this NDA Study is 10.15154/1526460.
